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The junctional sarcoplasmic reticulum (jSR) of skeletal muscle cells contains
several proteins that participate to the mechanisms of Ca2þ release in the pro-
cess of excitation-contraction coupling. Among these proteins, ryanodine re-
ceptor, triadin, junctin and calsequestrin have been found to associate into a sta-
ble complex. We recently reported that assembly of jSR domains is
accompanied by a strong decrease in the mobility fraction of jSR proteins (Cu-
simano et al., PNAS 2009). In particular, we found that the mobility of triadin
appeared to be mediated by its intraluminal region (aa 232-729). In order to
identify the minimal regions required for association of triadin to the jSR, de-
letion mutants of the luminal domain (triadin D232-440 and triadin D441-729)
were generated and expressed in primary muscle myotubes. Analysis of the mo-
bility fraction of these mutants showed that they do not differ from wild type
triadin, indicating that either one of the two regions is sufficient to provide
a strong association of the protein to the jSR. Interestingly, we found that the
luminal region of triadin contains several defined domains, including a coiled
coil region and short amino acids repeats, that are present in the region between
aa 232-440 and aa 441-729, where they may mediate protein-protein interac-
tions. Results on the role of these amino acid repeats in mediating triadin asso-
ciation with the jSR will be reported.
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We used multi-exponential analysis of time-resolved (TR) fluorescence decays
to investigate the array of distances underlying fluorescence resonance energy
transfer (FRET) between donors and acceptors bound within functional RyR
channels in sarcoplasmic reticulum membranes. Previously, we have used
steady-state (SS) FRET to demonstrate that CaM is oriented with the N-lobe
proximal to the FKBP12.6 subunit on each lateral face of the RyR tetrameric
complex (Cornea et al. 2009). Here, we used cysteine mutagenesis and sulfhy-
dryl-specific fluorescent labeling to attach Alexa Fluor (AF) donor probes to
single-cysteines at FKBP12.6 sites 49 or 85 (denoted D49 and D85), and accep-
tor probes to calmodulin (CaM) N-lobe sites 26 or 34 (denoted A26 and A34).
The fluorescence of RyR-bound donor-labeled FKBP12.6 was decreased in the
presence of saturating acceptor-labeled CaM, indicating FRET. Fo¨rster analysis
of TR- and SS-FRET data of donor/acceptor pairs AF350/AF488 and AF488/
AF568 (with different ranges of sensitivity) yielded similarly-ranked energy
transfer efficiencies: D85/A26 R D49/A26 > D49/D34 > D85/34. Distances
calculated from these FRET efficiencies are remarkably similar for the two dif-
ferent donor/acceptor probe pairs. However, this kind of analysis can extract
only averaged distances from an RyR sample in which distinct biophysical
states are known to co-exist. Further multi-exponential analysis of the donor-
only (AF350-FKBP12.6) and donorþacceptor (AF350-FKBP12.6/AF488-
CaM) TR-FRET data sets resolved at least two simultaneous distance popula-
tions for each pair of labeled sites. These distances and their distribution re-
sponded to changes in [Ca2þ]. We conclude that TR-FRET provides a powerful
approach for resolving dynamic transitions between structural states within
functional, multimeric RyR channels. Further studies will aim to determine
whether these findings reflect transitions between different conformations of
CaM itself, or of the underlying RyR channel.
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FK506-binding proteins FKBP12.6 and FKBP12 are associated with the car-
diac ryanodine receptor (RyR2), and PKA dependent hyperphosphorylation
of RyR2 has been proposed to interrupt the FKBP12.6-RyR2 interaction and
activate RyR2 opening. However, the physiological function of FKBP12.6/
12.0 in cardiac myocytes and the role of PKA-dependent RyR2 phosphoryla-
tion are controversial. We used permeabilized rat ventricular myocytes, and flu-
orescently-labeled FKBP12.6/12.0 to directly measure in situ binding ofFKBP12.6/12.0 to RyR2, with simultaneous Ca sparks measurements as an
RyR2 functional index. We found that both FKBP12.6 and FKBP12 concen-
trate at the Z-line, consistent with RyR2 binding. However, only FKBP12.6 in-
hibits resting RyR2 activity. Assessment of fluorescent FKBP binding at the Z-
line of permeabilized myocytes revealed a high affinity of FKBP12.6-RyR2
(Kd ¼ 0.97 5 0.1 nM) and much lower affinity of FKBP12-RyR2 (Kd ¼
2065 70 nM). Fluorescence recovery after photobleach of FKBP in myocytes
confirmed these different affinities and showed that the main difference was in
koff. Activation of RyR2 phosphorylation by PKA had no significant affect on
either binding kinetics or affinity of FKBP12.6/12-RyR2. Using quantitative
immunoblots, we determined the concentration of endogenous FKBP12 in in-
tact myocytes was ~1 mM, while FKBP12.6 is at most ~150 nM. Taken to-
gether, our data suggest that FKBP12.6 binds to and stabilizes the resting
RyR2 but cAMP-dependent RyR2 phosphorylation does not dissociate
FKBP12.6 (or FKBP12) from RyR2 in the myocyte environment. More impor-
tant, this study highlights the importance of in situ binding properties measure-
ment and clarifies some aspects of controversy.
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It is widely believed, that in striated muscle, FKBP12.6 selectively binds to
RyR2 but that FKBP12 is the binding partner for RyR1. Few studies have ad-
dressed whether FKBP12 can modulate RyR2 function or whether FKBP12.6
can affect RyR1. Our recent single-channel studies show that FKBP12 activates
RyR2 with nanomolar affinity but because binding is rapidly reversible, this in-
teraction is unlikely to be detected by Western blot analysis. We have therefore
compared how FKBP12 and FKBP12.6 affect the single-channel properties of
RyR1 and RyR2 reconstituted into bilayers. Using Ca2þ as the permeant ion,
cytosolic addition of 500 nM FKBP12 significantly decreased the open proba-
bility (Po) of RyR1 from 0.0215 0.005 (SEM; n ¼ 4) in controls to 0.0015
0.001 (SEM; n ¼ 4; P<0.05). This effect was irreversible after perfusing away
the FKBP12. In contrast, 200 nM and 1 mMFKBP12.6 increased RyR1 Po. This
effect was also irreversible after washout of FKBP12.6 but could be antagon-
ised by addition of FKBP12. In comparison, FKBP12 is a reversible activator
of RyR2 whereas FKBP12.6 has little intrinsic action itself but can antagonise
FKBP12-induced activation. The presence or absence of FKBP12/12.6 did not
lead to the appearance of sub-conductance gating states in RyR2 but, after FK-
506 treatment or addition of FKBP12.6 to RyR1, sub-conductance states were
frequently observed. Since FKBP12 activates RyR2 but is antagonised by
FKBP12.6, and FKBP12.6 activates RyR1 but is antagonised by FKBP12,
the ratio of FKBP12/FKBP12.6 levels in the cytoplasm will be critical in deter-
mining RyR activity in situ. Changes in the cytoplasmic FKBP12/FKBP12.6
ratio may be important in heart failure, where it has been suggested that less
FKBP12.6 binds to RyR2.
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A huge body of evidence suggests that FKBP12.6, which binds tightly to RyR2,
is an important physiological regulator of cardiac excitation-contraction (EC)
coupling yet its mechanism of action remains elusive. Our recent single-chan-
nel studies now reveal that RyR2 activity may be controlled by the opposing
actions of FKBP12.6 and FKBP12. To investigate how these proteins regulate
RyR2 function in cardiac cells we have used rapamycin to dissociate FKBP12
and FKBP12.6 from RyR2 in isolated rat permeabilised ventricular myocytes.
In control myocytes perfused with Fluo-5F, spontaneous waves of Ca2þ-in-
duced Ca2þ-release were induced by 234 nM Ca2þ in the mock cytoplasmic so-
lution. Treatment for 4-6 min with 20 mM rapamycin, reduced the frequency of
the Ca2þ-waves from 0.5750.07 Hz to 0.1850.05 Hz (SEM; n¼5; P<0.002)
and led to the appearance of ‘mini-waves’ that did not propagate throughout the
cell. Rapamycin treatment also increased baseline Fluo-5F fluorescence inten-
sities by 204547% (SEM; n¼8; P<0.05), an effect that was completely re-
versed by perfusion with a physiological level of FKBP12 (3 mM; n¼4;
P<0.001) but not with 200 nM FKBP12.6 (n=4). In rapamycin-treated cells,
FKBP12 (from 0.1550.06 Hz to 0.2750.07 Hz (SEM; n¼6; P<0.025) was
